Drugmakers' stocks in Europe and India slipped on Wednesday after U.S. President Donald Trump reiterated plans for a "major" ...

Reports indicate that India supplies over 45% of generic and around 15% of biosimilar medicines used in the US.

“In case the US starts imposing tariffs on the pharma sector, it will impact both countries,” analysts from HDFC Securities ...

Nifty Pharma index sinks over 2% as Indian drugmakers face tariff heat; Gland, Aurobindo, Biocon, Sun Pharma among top losers ...

Indian pharmaceutical companies are crucial to the U.S. healthcare system, filling four out of every ten prescriptions in ...

Nifty Pharma index declined as much as 2.64% on Wednesday compared to 0.56% decline in the benchmark Nifty 50.

Speaking at the Republican NRCC event, US President Donald Trump said that major tariffs on Pharmaceuticals will be in place ...

Continuing his economic onslaught, US President Donald Trump said on Tuesday that Washington is planning to announce a "major ...

India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to ...

Pharmaceutical stocks plummet amid tariff war fears, Nifty Pharma index down 2.75% in Monday stock market meltdown.

The worst-hit company was Gland Pharma, which fell more than 11.4%. Divis Labs and Laurus Labs also saw declines of more than ...